Search
Search Results
##search.searchResults.foundPlural##
-
CLONAL HEMATOPOIESIS: ROLE IN HEMATOLOGIC NON-HEMATOLOGIC MALIGNANCIES CLONAL HEMATOPOIESIS AND MALIGNANCIES
2942PDF: 889HTML: 1870 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2117PDF: 1688HTML: 375 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1331PDF: 822HTML: 129 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1370HTML: 391PDF: 818 -
Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases Acquired Sideroblastic Anemia
950PDF: 581HTML: 337 -
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1778PDF: 965HTML: 141 -
PATHOBIOLOGY OF HODGKIN LYMPHOMA
3214PDF: 1427HTML: 5844Fig1-Ag-Pil: 223Ag-Pil Fig.2: 227 -
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-T Cells
946PDF: 1204HTML: 108 -
SOLITARY PLASMACYTOMA
3845PDF: 2174HTML: 1220fIGURES 1,2: 213 -
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1519PDF: 941HTML: 222 -
IMPORTANCE OF CLASSICAL MORPHOLOGY IN THE DIAGNOSIS OF MYELODYSPLASTIC SYNDROME
3290PDF: 2264HTML: 23321Untitled: 203Untitled: 216Untitled: 231 -
IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA? MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA
2544PDF: 1130HTML: 139 -
-
-
NPM1 MUTATED, BCR-ABL1 POSITIVE MYELOID NEOPLASMS: REVIEW OF LITERATURE NPM1 mutated, BCR-ABL1 positive myeloid neoplasms
1652PDF: 1173HTML: 200 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2767PDF: 1807HTML: 3665Pellagatti Fig 1: 214Pellagatti Fig. 2: 209 -
HEPATITIS C VIRUS INFECTION AND LYMPHOMA
994PDF: 537HTML: 7810 -
APLASTIC ANEMIA AND VIRAL HEPATITIS
1255PDF: 527HTML: 23042 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1187PDF: 1061HTML: 200 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3223PDF: 1008HTML: 2023 -
Routine inflammatory markers are elevated in myelodysplastic syndromes at presentation Inflammatory marker elevation in MDS
872PDF: 647HTML: 203 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3678PDF: 1435HTML: 182 -
THERAPEUTIC GENE EDITING FOR HEMOGLOBINOPATHIES Gene therapy for Hemoglobinopathies.
2118PDF: 1268Html: 280 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
1823HTML: 1442PDF: 1078 -
DIAGNOSTIC UTILITY OF FLOW CYTOMETRY IN MYELODYSPLASTIC SYNDROMES.
4800PDF: 1796HTML: 2132 -
RARE CYTOGENETIC ABNORMALITIES IN MYELODYSPLASTIC SYNDROMES
3760PDF: 1652HTML: 11579Figures Haase: 198 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3578PDF: 881HTML: 6710 -
OUTBREAK OF BURKHOLDERIA CEPACIA INFECTION: A SYSTEMATIC STUDY IN A HEMATOLOGY-ONCOLOGY UNIT OF A TERTIARY CARE HOSPITAL FROM EASTERN INDIA.
2182PDF: 925HTML: 408Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 213UntitOutbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern Indialed: 341Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 240Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 176Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 188Outbreak of Burkholderia cepacia infection: a systematic study in a hematolo-oncology unit of a tertiary care hospital from Eastern India: 257 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1051PDF: 1044HTML: 95







